1. Dasgupta J, Tincello DG. Interstitial cystitis/bladder pain syndrome: an update. Maturitas . 2009;64:212-217.
2. Hanno PM, Burks DA, Clemens JQ, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: American Urological Association (AUA) Guideline (2011). www.auanet.org/education/guidelines/ic-bladder-pain-syndrome.cfm. Accessed June 5, 2013.
3. Evans RJ; University of Tennessee Advanced Studies in Pharmacy. Pathophysiology and clinical presentation of interstitial cystitis (2005). www.utasip.com/files/articlefiles/pdf/XASIP_Issue_Mar_p8_14.pdf. Accessed June 5, 2013.
4. Sant GR. Etiology, pathogenesis, and diagnosis of interstitial cystitis. Rev Urol . 2002;(4 suppl 1):S9-S15.
5. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn . 2002;21:167-178.
6. van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol . 2008;53:60-67.
7. Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review.
J Urol . 2007;177:450-456.
8. Kusek JW, Nyberg LM. The epidemiology of interstitial cystitis: is it time to expand our definition? Urology . 2001;57(6 suppl 1):95-99.
9. Clemens JQ, Meenan RT, Rosetti MC, et al. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol . 2005;173:98-102.
10. Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol . 2011;186:540-544.
11. Rosamilia A, Dwyer PL. Pathophysiology of interstitial cystitis. Curr Opin Obstet Gynecol . 2000;12:405-410.
12. Grover S, Srivastava A, Lee R, et al. Role of inflammation in bladder function and interstitial cystitis. Ther Adv Urol . 2011;3:19-33.
13. Rosenberg MT, Page S, Hazzard MA. Prevalence of interstitial cystitis in a primary care setting. Urology . 2007;69(4 suppl):S48-S52.
14. Evans RJ. Treatment approaches for interstitial cystitis: multimodality therapy. Rev Urol . 2002;(4 suppl 1):S16-S20.
15. Wesselmann U. Interstitial cystitis: a chronic visceral pain syndrome. Urology . 2001;57(6 suppl 1):102.
16. Hosseini A, Ehrén I, Wiklund NP. Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis.
J Urol. 2004;172(6 pt 1):2261-2265.
17. Ho MH, Bhatia NN, Khorram O. Physiologic role of nitric oxide and nitric oxide synthase in female lower urinary tract. Curr Opin Obstet Gynecol . 2004;16:423-429.
18. Rosenberg MT, Newman DK, Page SA. Interstitial cystitis/painful bladder syndrome: symptom recognition is key to early identification, treatment. Cleve Clin J Med . 2007;74:854-862.
19. Driscoll A, Teichman JM. How do patients with interstitial cystitis present?
J Urol . 2001;166:2118-2120.
20. Parsons CL. Interstitial cystitis: epidemiology and clinical presentation. Clin Obstet Gynecol . 2002;45:242-249.
21. Hanno PM, Landis JR, Matthews-Cook Y, et al. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol . 1999;161:553-557.
22. Whitmore KE, Theoharides TC. When to suspect interstitial cystitis. J Fam Pract . 2011;60:340-348.
23. Butrick CW, Howard FM, Sand PK. Diagnosis and treatment of interstitial cystitis/painful bladder syndrome: a review. J Womens Health (Larchmt) . 2010;19:1185-1193.
24. O’Leary MP, Sant GR, Fowler FJ Jr, et al. The interstitial cystitis symptom index and problem index. Urology . 1997;49(5A suppl):58-63.
25. Nickel JC. Forensic dissection of a clinical trial: lessons learned in understanding and managing interstitial cystitis. Rev Urol . 2010;12:e78-e85.
26. Anger JT, Zabihi N, Clemens JQ, et al. Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome. Int Urogynecol J . 2011;22:395-400.
27. Nickel JC. Interstitial cystitis: characterization and management of an enigmatic urologic syndrome. Rev Urol . 2002;4:112-121.
28. Dell JR. Interstitial cystitis/painful bladder syndrome: appropriate diagnosis and management. J Womens Health (Larchmt). 2007;16:1181-1187.
29. National Kidney and Urologic Diseases Information Clearinghouse. Interstitial cystitis/painful bladder syndrome (2011). NIH Publication No. 11–3220. http://kidney.niddk.nih.gov/kudiseases/pubs/interstitialcystitis/IC_PBS_T_508.pdf. Accessed June 5, 2013.
30. Davis EL, El Khoudary SR, Talbott EO, et al. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol . 2008;179:177-185.
31. Pinto R, Lopes T, Silva J, et al. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis. J Urol . 2013;189:548-553.
32. Pinto R, Lopoes T, Frias B, et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol . 2010;58:360-365.
33. Gottsch HP, Miller JL, Yang CC, Berger RE. A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome. Neurourol Urodyn . 2011; 30:93-96.
34. Neuhaus J, Schwalenberg T, Horn LC, et al. New aspects in the differential diagnosis and therapy of bladder pain syndrome/interstitial cystitis. Adv Urol . 2011;2011:639479.
